In vitro susceptibilities of 126 clinical isolates of Yersinia enterocolitica to 21 beta-lactam antibiotics - PubMed (original) (raw)
In vitro susceptibilities of 126 clinical isolates of Yersinia enterocolitica to 21 beta-lactam antibiotics
M J Hornstein et al. Antimicrob Agents Chemother. 1985 May.
Abstract
The MICs of 21 beta-lactam antibiotics were measured against 126 clinically significant and epidemiologically unrelated Yersinia enterocolitica isolates. The most active antimicrobial agents tested (geometric means of MICs) were ceftriaxone, cefotaxime, ceftizoxime, and cefmenoxime (0.06 to 0.08 micrograms/ml). Mezlocillin (1.36 micrograms/ml) and piperacillin (1.57 micrograms/ml) were the most active penicillins. Aztreonam and imipenem had MICs of 0.44 and 0.24 micrograms/ml. All isolates exhibited some degree of resistance against ampicillin (MICs, greater than or equal to 4 micrograms/ml) and cephalothin (MICs, greater than or equal to 8 micrograms/ml). Cephalosporinase or penicillinase activities were expressed by all isolates. A principal component analysis of MIC data separated the major serotypes (O3, O9, O8, and O5,27). The MCBs of 14 newer beta-lactams were measured against 10 clinical isolates. On the basis of the ratio of MBC to MIC (expressed in dilution factors), a real bactericidal activity was only observed for imipenem (MBC/MIC = 1). For the other newer beta-lactams, the ratios ranged from 4 to 8.
Similar articles
- Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli to 12 beta-lactam agents and combinations with beta-lactamase inhibitors.
Tajada P, Gomez-Graces JL, Alós JI, Balas D, Cogollos R. Tajada P, et al. Antimicrob Agents Chemother. 1996 Aug;40(8):1924-5. doi: 10.1128/AAC.40.8.1924. Antimicrob Agents Chemother. 1996. PMID: 8843305 Free PMC article. - Susceptibilities of beta-lactamase-positive and -negative strains of Campylobacter coli to beta-lactam agents.
Lachance N, Gaudreau C, Lamothe F, Turgeon F. Lachance N, et al. Antimicrob Agents Chemother. 1993 May;37(5):1174-6. doi: 10.1128/AAC.37.5.1174. Antimicrob Agents Chemother. 1993. PMID: 8390812 Free PMC article. - In vitro activity of combinations of beta-lactam antibiotics with beta-lactamase inhibitors against cephalosporinase-producing bacteria.
Kitzis MD, Ferré B, Coutrot A, Acar JF, Gutmann L. Kitzis MD, et al. Eur J Clin Microbiol Infect Dis. 1989 Sep;8(9):783-8. doi: 10.1007/BF02185845. Eur J Clin Microbiol Infect Dis. 1989. PMID: 2556277 - Evolution of beta-lactamase inhibitors.
Rolinson GN. Rolinson GN. Rev Infect Dis. 1991 Jul-Aug;13 Suppl 9:S727-32. doi: 10.1093/clinids/13.supplement_9.s727. Rev Infect Dis. 1991. PMID: 1656513 Review. - Beta-lactamase inhibitors from laboratory to clinic.
Bush K. Bush K. Clin Microbiol Rev. 1988 Jan;1(1):109-23. doi: 10.1128/CMR.1.1.109. Clin Microbiol Rev. 1988. PMID: 3060240 Free PMC article. Review.
Cited by
- Yersinia enterocolitica: the charisma continues.
Bottone EJ. Bottone EJ. Clin Microbiol Rev. 1997 Apr;10(2):257-76. doi: 10.1128/CMR.10.2.257. Clin Microbiol Rev. 1997. PMID: 9105754 Free PMC article. Review. - A Structure-Based Classification of Class A β-Lactamases, a Broadly Diverse Family of Enzymes.
Philippon A, Slama P, Dény P, Labia R. Philippon A, et al. Clin Microbiol Rev. 2016 Jan;29(1):29-57. doi: 10.1128/CMR.00019-15. Clin Microbiol Rev. 2016. PMID: 26511485 Free PMC article. Review. - The comparative activity of pefloxacin, enoxacin, ciprofloxacin and 13 other antimicrobial agents against enteropathogenic microorganisms.
Vanhoof R, Hubrechts JM, Roebben E, Nyssen HJ, Nulens E, Leger J, De Schepper N. Vanhoof R, et al. Infection. 1986 Nov-Dec;14(6):294-8. doi: 10.1007/BF01643966. Infection. 1986. PMID: 3546145 - Failure of newer beta-lactam antibiotics for murine Yersinia enterocolitica infection.
Scavizzi MR, Alonso JM, Philippon AM, Jupeau-Vessieres AM, Guiyoule A. Scavizzi MR, et al. Antimicrob Agents Chemother. 1987 Apr;31(4):523-6. doi: 10.1128/AAC.31.4.523. Antimicrob Agents Chemother. 1987. PMID: 3475033 Free PMC article.
References
- Ann N Y Acad Sci. 1970 Oct 30;174(2):488-502 - PubMed
- Presse Med. 1971 Feb 13;79(8):345-8 - PubMed
- Antimicrob Agents Chemother. 1972 Apr;1(4):283-8 - PubMed
- Appl Microbiol. 1974 Sep;28(3):469-73 - PubMed
- J Infect Dis. 1975 Apr;131(4):447-51 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical